Published September 2, 2010
| Version v1
Patent
Open
VITAMIN D AND VITAMIN D ANALOGS OR DERIVATIVES AS NEW ANTI-HYPERTENSIVE AGENTS
Contributors
Patent applicant:
Description
Methods and compositions to suppress renin expression and blood pressure in mammals are disclosed. Vitamin D and its analogues and derivatives, including Gemini compounds, are negative regulators of renin synthesis and blood pressure. Renin expression and plasma angiotensin II production were increased several fold in vitamin D receptor (VDR) null mice, leading to hypertension, cardiac hypertrophy and increased water intake. Vitamin D or its analogue-mediated regulation of renin expression and blood pressure is independent of calcium metabolism. Vitamin D analogues or derivatives are novel preventive or therapeutic anti-hypertension agents. Assays to identify novel vitamin D analogues or derivatives as anti-hypertensive agents are disclosed.
Files
US20100222307.pdf
Files
(1.5 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:b95b0567b96cad608b0960f9df3db7b9
|
1.5 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 71513310 A
- Patent number
- US 2010/0222307 A1
- Other
- oai:uchicago.tind.io:9021
Dates
- Patent filed
-
2010-03-01